Zebrafish Multiple Sclerosis / Demyelination Models

Introduction

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system characterized by immune-mediated demyelination, oligodendrocyte injury, axonal damage, and incomplete remyelination. Loss of myelin disrupts saltatory nerve conduction and contributes to neurological disability. Patients may present with visual disturbance, sensory deficits, limb weakness, impaired coordination, fatigue, cognitive symptoms, and progressive motor dysfunction. MS typically affects young adults and is more common in women. Long-term disease progression can lead to irreversible neuroaxonal loss and accumulated disability.

Current MS therapies mainly reduce immune activity and relapse frequency, but treatments that directly promote remyelination and restore neural function remain limited. Key research challenges include identifying mechanisms of oligodendrocyte loss, enhancing oligodendrocyte precursor cell differentiation, promoting new myelin sheath formation, and evaluating remyelination-promoting compounds. Zebrafish are useful for demyelination and remyelination research because myelin biology, oligodendrocyte development, and major myelin genes are conserved. Transparent larvae and myelin reporter lines enable live imaging of oligodendrocytes, myelin sheaths, and drug effects in vivo.

Why Zebrafish?

• Conserved Myelin Biology: Myelin formation and oligodendrocyte biology are conserved in zebrafish.
• Live Imaging: Transparent larvae enable live imaging of myelination and demyelination.
• Reporter Screening: Reporter lines support quantitative screening of pro-myelination compounds.
• Functional Endpoints: Models allow rapid in vivo assessment of locomotor and myelin-related endpoints.

Available Zebrafish Disease Models

We provide complementary zebrafish models spanning inducible oligodendrocyte ablation, myelin reporter-based screening, and genetic myelin-development models:

Phenotypic Evaluation

Key Applications

• Remyelination-Promoting Drug Screening: Evaluate whether candidate compounds enhance oligodendrocyte recovery, increase myelin reporter signal, or accelerate myelin sheath regeneration after demyelination.
• Oligodendrocyte Biology Studies: Investigate mechanisms controlling oligodendrocyte specification, differentiation, maturation, and myelin sheath formation in vivo.
• Target Validation for Myelin Repair: Assess candidate genes, signaling pathways, or disease-associated variants involved in demyelination, remyelination failure, or oligodendrocyte survival.
• Functional Assessment: Link myelin loss or recovery with locomotor endpoints, including swimming distance, velocity, and movement duration.
• Early-Stage Compound Profiling: Prioritize small molecules or biologics using imaging-based myelin endpoints and behavioral readouts before advancing to mammalian MS models.

Study Examples

A transgenic zebrafish model enables inducible oligodendrocyte ablation and remyelination analysis. The authors generated Tg(mbp:nfsB-egfp) zebrafish, in which nitroreductase-EGFP was expressed in oligodendrocytes under the mbp promoter. Metronidazole treatment selectively ablated oligodendrocytes, resulting in demyelination and reduced locomotor activity, including decreased movement distance and velocity. After metronidazole withdrawal, EGFP and MBP signals recovered over time, indicating remyelination, and locomotor behavior improved.

Fig. 1. Metronidazole-induced oligodendrocyte ablation causes demyelination followed by recovery of myelin signals after treatment withdrawal (Fang Y, Lei X, et al., 2015).

Targeted oligodendrocyte ablation creates zebrafish CNS demyelination models. This study used transgenic strategies to selectively ablate oligodendrocytes in the zebrafish central nervous system. The authors applied targeted cell ablation approaches to remove oligodendrocyte-lineage cells and assessed resulting demyelination phenotypes. The work demonstrated that zebrafish can be engineered to model oligodendrocyte loss in vivo, providing a platform to study myelin disruption and repair.

Fig. 1. Targeted ablation of oligodendrocytes disrupts CNS myelin in zebrafish larvae (Chung AY, Kim PS, et al., 2013).

References

1. Fang Y, Lei X, et al. A novel model of demyelination and remyelination in a GFP-transgenic zebrafish. Biology Open 4(1), 62–68 (2015).
2. Chung AY, Kim PS, et al. Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS. Molecules and Cells 36(1), 82–87 (2013).